Company News

Dr. Gattoni-Celli and Dr. Kindy were interviewed by Dennis Quick of the Charleston Business Journal

CHARLESTON -- Last year, Dr. Sebastiano Gattoni-Celli and Mark Kindy, both of the Medical University of South Carolina, launched SemiAlloGen Inc., a biotech company developing vaccines and therapeutic treatments for Alzheimer’s disease and cancer...

Read the full article here.

SemiAlloGen, Inc receives grant from South Carolina EPSCoR/IDeA Program

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs provide financial resources for small businesses in the United States for research and development of relevant technologies. Ten federal agencies provide about $1.2 billion annually to fund Research and Development (R&D) efforts in a wide range of topic areas. These programs provide opportunities to nurture the development of innovative businesses and enable economic development and diversification.

Back to top

Product Updates

Dr. Gattoni-Celli recieved a grant from The Cancer Treatement Research Foundation (CTRF)  

Patient Impact: This treatment has allowed many patients with melanoma to live much longer than expected. Mr. Hamlin is alive three years after treatment even though he was told he had less than six months to live. Dr. Gattoni-Celli published three articles in reputable, peer-reviewed journals.

View CTRF's Research Grants

Back to top

Check back for Press Releases as they become available.

Back to top